Perbedaan Garuda Maintenance Facility Aero Asia Tbk. dan Organon Pharma Indonesia Tbk.: Garuda Maintenance Facility Aero Asia Tbk. diperdagangkan di Rp58 (kapitalisasi pasar 7,12 T, volume 24 jam 61,66 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Garuda Maintenance Facility Aero Asia Tbk. jauh lebih besar — sekitar 68,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| GMFI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 7,12 T | 104,4 M |
Volume | 61,66 jt | — |
Lot | 616,63 rb | — |
Perputaran | 3,52 M | — |
Harga Rata-rata | 57,03 | — |
Nilai Transaksi | 3,52 M | — |
Harga Ekuilibrium Indikatif | 58 | — |
Volume Ekuilibrium Indikatif | 17,24 rb | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
Starting out in 1949, GMF AeroAsia originated as the Technical Division of Garuda Indonesia Airlines at the Kemayoran and Halim Perdanakusuma airports in Jakarta, Indonesia. In 1984, GMF AeroAsia was relocated to Soekarno-Hatta International Airport and rebranded itself as the Division of Maintenance & Engineering (M & E), which eventually developed into an independent business unit.Subsequently in 1998, the M & E Division transformed into the Strategic Business Unit (SBU-GMF), handling all Garuda Indonesia's fleet maintenance activities, thus honing its competitive edge. Eventually in 2002 SBU-GMF was spun off from Garuda Indonesia, and officially became an independent entity under the name of PT Garuda Maintenance Facility Aero Asia.GMF AeroAsia is now rightly considered as the best and biggest aircraft maintenance companies in the region, providing the excellence of integrated solutions for all customers around the world.PT. Garuda Maintenance Facility Aero Asia Tbk (the Company) was established based on deed No. 93 dated April 26, 2002 of Arry Supratno, SH, notary in Jakarta.
Selengkapnya di halaman GMFI →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →